Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F

The majority of patients with myeloproliferative neoplasms (MPNs) carry a somatic JAK2-V617F mutation. Because additional mutations can precede JAK2-V617F, it is questioned whether JAK2-V617F alone can initiate MPN. Several mouse models have demonstrated that JAK2-V617F can cause MPN; however, in al...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundberg, Pontus, Takizawa, Hitoshi, Kubovcakova, Lucia, Guo, Guoji, Hao-Shen, Hui, Dirnhofer, Stephan, Orkin, Stuart H., Manz, Markus G., Skoda, Radek C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203945/
https://www.ncbi.nlm.nih.gov/pubmed/25288396
http://dx.doi.org/10.1084/jem.20131371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203945/
https://www.ncbi.nlm.nih.gov/pubmed/25288396
http://dx.doi.org/10.1084/jem.20131371

Ejemplares similares